Liquid Biopsy Market Size, Share, Trends, Global Forecasts, Competitive Landscapes and Growth Opportunity: 2022-2028 {{ currentPage ? currentPage.title : "" }}

Market Insights

The liquid biopsy market was valued at US$ 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach US$ 7.64 billion in 2028.

What is Liquid Biopsy?

Liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, mainly blood. This technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive.

Market Drivers

  • Increase in the number of cancer patients,

  • Increasing demand for non-invasive treatment procedures,

  • Growing awareness about the benefits of liquid biopsy,

  • Advantages such as low cost, rapid and accurate results, and early detection of diseases.

Read More: https://www.stratviewresearch.com/422/liquid-biopsy-diagnostic-market.html

{{{ content }}}